药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Spectinomycin
Levonordefrin
The therapeutic efficacy of Midomafetamine can be increased when used in combination with Levonordefrin.
Spectinomycin
Droxidopa
The therapeutic efficacy of Midomafetamine can be increased when used in combination with Droxidopa.
Spectinomycin
Valproate bismuth
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Valproate bismuth.
Spectinomycin
Gepefrine
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Gepefrine.
Spectinomycin
Methoxyphenamine
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Methoxyphenamine.
Spectinomycin
Mephedrone
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Mephedrone.
Spectinomycin
Ritobegron
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Ritobegron.
Spectinomycin
Iofetamine I-123
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Iofetamine I-123.
Spectinomycin
Methylthioninium
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Methylthioninium.
Spectinomycin
Dextroamphetamine
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Dextroamphetamine.
Spectinomycin
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with Chlorphentermine.
Spectinomycin
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of serotonin syndrome can be increased when Midomafetamine is combined with 2,5-Dimethoxy-4-ethylamphetamine.
Spectinomycin
Mephentermine
The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Midomafetamine.
Spectinomycin
Dexfenfluramine
The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Midomafetamine.
Spectinomycin
Isoniazid
The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Midomafetamine.
Spectinomycin
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Midomafetamine.
Spectinomycin
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Midomafetamine.
Spectinomycin
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Midomafetamine.
Spectinomycin
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Midomafetamine.
Spectinomycin
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Midomafetamine.